This inventor holds 1 USPTO granted patent. Top assignee: Universitetet I Tromsø—norges Arktiske Universitet. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Man Kumari Gurung: Innovator in Neuraminic Acid Production
Introduction
Man Kumari Gurung is a notable inventor based in Tromsø, Norway. She has made significant contributions to the field of biochemistry, particularly in the production of neuraminic acid and its derivatives. Her innovative work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Man Kumari Gurung holds a patent for the invention titled "Use of a N-acetylneuraminate lyase derived from the bacterium in the production of neuraminic acid and derivatives thereof." This patent outlines methods for producing neuraminic acid or its derivatives under alkaline conditions. The invention utilizes a N-acetylneuraminate lyase isolated from the psychrophilic bacterium LFI1238, which exhibits improved characteristics under alkaline conditions.
Career Highlights
Gurung is affiliated with the University of Tromsø—Norges Arktiske Universitet, where she conducts her research. Her work has garnered attention for its potential to enhance the efficiency of neuraminic acid production, which is crucial for various industrial applications.
Collaborations
Some of her notable coworkers include Inger Lin Uttakleiv Ræder and Bjørn Altermark. Their collaborative efforts contribute to the advancement of research in the field of biochemistry.
Conclusion
Man Kumari Gurung's innovative work in the production of neuraminic acid showcases her expertise and dedication to advancing biochemistry. Her contributions are paving the way for future developments in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile